28473531|t|Oncogenic RAS regulates long non-coding RNA Orilnc1 in human cancer
28473531|a|RAS and its downstream cascades transmit cellular signals resulting in increased transcription of genes involved in cell growth and division. Protein-coding gene targets of RAS signaling have been characterized extensively, but long non-coding RNAs (lncRNA) regulated by these processes have not. Using a custom-designed lncRNA microarray, we identified the lncRNA Orilnc1 as a genetic target of RAS that is critical for RAS oncogenicity. Orilnc1 expression was regulated by RAS-RAF-MEK-ERK signaling via the transcription factor AP1. Orilnc1 was highly expressed in BRAF-mutant cancers such as melanoma. Silencing of Orilnc1 blocked tumor cell proliferation and growth in vitro and in vivo. Additionally, Orilnc1 blockade reduced expression of Cyclin E1 and induced G1/S cell cycle arrest in tumor cells. Taken together, our results identify Orilnc1 as a novel, non-protein mediator of RAS/RAF activation which may serve as a therapeutic target in RAS/RAF-driven cancers.
28473531	0	13	Oncogenic RAS	T028	C0034678
28473531	14	23	regulates	T045	C0017263
28473531	24	51	long non-coding RNA Orilnc1	T114,T123	C3494264
28473531	55	60	human	T016	C0086418
28473531	61	67	cancer	T191	C0007097
28473531	68	71	RAS	T028	C0034678
28473531	80	99	downstream cascades	T028	C0017337
28473531	100	108	transmit	T169	C0332289
28473531	109	125	cellular signals	T043	C0037083
28473531	126	138	resulting in	T169	C0332294
28473531	139	148	increased	T081	C0205217
28473531	149	171	transcription of genes	T045	C0040649
28473531	184	195	cell growth	T043	C0007595
28473531	200	208	division	T043	C0007590
28473531	210	229	Protein-coding gene	T028	C3839127
28473531	230	237	targets	T169	C1521840
28473531	241	254	RAS signaling	T044	C1514731
28473531	265	278	characterized	T052	C1880022
28473531	296	316	long non-coding RNAs	T114,T123	C3494264
28473531	318	324	lncRNA	T114,T123	C3494264
28473531	326	335	regulated	T045	C0017263
28473531	345	354	processes	T067	C1522240
28473531	373	406	custom-designed lncRNA microarray	T075	C3853655
28473531	411	421	identified	T080	C0205396
28473531	426	440	lncRNA Orilnc1	T114,T123	C3494264
28473531	446	453	genetic	T169	C0314603
28473531	454	460	target	T169	C1521840
28473531	464	467	RAS	T028	C0034678
28473531	476	484	critical	T080	C1511545
28473531	489	492	RAS	T028	C0034678
28473531	493	505	oncogenicity	T201	C3828709
28473531	507	514	Orilnc1	T114,T123	C3494264
28473531	515	525	expression	T045	C0017262
28473531	530	539	regulated	T045	C0017263
28473531	543	568	RAS-RAF-MEK-ERK signaling	T044	C0037080
28473531	577	601	transcription factor AP1	T026	C3888349
28473531	603	610	Orilnc1	T114,T123	C3494264
28473531	622	631	expressed	T045	C0017262
28473531	635	646	BRAF-mutant	T049	C1511021
28473531	647	654	cancers	T191	C0007097
28473531	663	671	melanoma	T191	C0025202
28473531	673	682	Silencing	T045	C0598496
28473531	686	693	Orilnc1	T114,T123	C3494264
28473531	694	701	blocked	T169	C0332206
28473531	702	726	tumor cell proliferation	T043	C0596290
28473531	731	737	growth	T043	C0007595
28473531	738	746	in vitro	T080	C1533691
28473531	751	758	in vivo	T082	C1515655
28473531	774	781	Orilnc1	T114,T123	C3494264
28473531	782	790	blockade	T169	C0332206
28473531	791	798	reduced	T080	C0392756
28473531	799	809	expression	T045	C1171362
28473531	813	822	Cyclin E1	T116,T123	C1259807
28473531	827	834	induced	T169	C0205263
28473531	835	857	G1/S cell cycle arrest	T044	C1517339
28473531	861	872	tumor cells	T025	C0597032
28473531	894	901	results	T169	C1274040
28473531	902	910	identify	T080	C0205396
28473531	911	918	Orilnc1	T114,T123	C3494264
28473531	924	929	novel	T080	C0205314
28473531	955	973	RAS/RAF activation	T040	C2265359
28473531	995	1006	therapeutic	T169	C0302350
28473531	1007	1013	target	T169	C1521840
28473531	1017	1039	RAS/RAF-driven cancers	T191	C0007097